Beijing Bio-targeting Therapeutics Technology Co., Ltd

This early-phase study tests a new treatment for people with recurrent high-grade glioma, a fast-growing brain cancer that has returned after standard therapy. The treatment combines a specially designed virus that targets cancer cells with an immunotherapy drug that helps the im…